CCTA Accurate for Assessing Angiographic Outcomes After BVS

Share this content:
CCTA Accurate for Assessing Angiographic Outcomes After BVS
CCTA Accurate for Assessing Angiographic Outcomes After BVS

MONDAY, July 24, 2017 (HealthDay News) -- Coronary computed tomography angiography (CCTA) is accurate for assessing angiographic outcomes after bioresorbable vascular scaffold (BVS) implantation, according to a study published online July 19 in JACC: Cardiovascular Imaging.

Carlos Collet, M.D., from the University of Amsterdam, and colleagues examined the diagnostic accuracy of CCTA for assessing angiographic outcomes after implantation of BVS. Two hundred thirty-eight patients (258 lesions) treated with BVS implantation underwent coronary angiography with intravascular ultrasound (IVUS) evaluation and CCTA at three-year follow-up in the ABSORB II study. The area under the receiver operating characteristic curve (AUC) was used to assess the diagnostic accuracy of CCTA.

The researchers found that with quantitative coronary angiography as reference, the mean difference in CCTA-derived minimum luminal diameter was 0.14 mm, whereas the mean difference in minimal luminal area (MLA) was 0.73 mm² with IVUS as reference. The AUC was 0.88 for the per-scaffold diagnostic accuracy of CCTA for detecting stenosis based on coronary angiography diameter stenosis ≥50 percent, with sensitivity and specificity of 80 and 100 percent, respectively; diagnostic accuracy based on IVUS MLA ≤2.5 mm² showed an AUC of 0.83. with sensitivity and specificity of 71 and 82 percent, respectively. For identifying patients with a significant lesion based on the IVUS criteria, the diagnostic accuracy of CCTA was similar to coronary angiography.

"CCTA has good diagnostic accuracy to detect in-scaffold luminal obstruction and to assess luminal dimensions after BVS implantation," the authors write. "CCTA might become the method of choice for the evaluation of patients treated with BVS."

Several authors are members of the International Advisory Board for Abbott Vascular.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Mortality Estimates Favor Annual Mammography From Age 40

Mortality Estimates Favor Annual Mammography From Age 40

Researchers estimate thousands of U.S. lives would be saved each year if mammograms started at age 40

Anti-Vaccine Info in Pregnancy May Delay Infant Immunization

Anti-Vaccine Info in Pregnancy May Delay Infant Immunization

Even if pregnant women later hear better info from doctors, they may still wait on vaccines

Hours Worked Impacted by Kids for Female, Not Male Doctors

Hours Worked Impacted by Kids for Female, Not ...

Findings from a national sample of dual-physician couples

is free, fast, and customized just for you!

Already a member?

Sign In Now »